MDGL
MADRIGAL PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$428.38
−0.77%Forward multiples
Based on analyst estimates
- P/E forward
- 225.54x
- P/E 2026E
- —
- P/E 2027E
- 77.07x
- P/E 2028E
- 20.94x
- P/S forward
- 5.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.90x
- Price / sales
- 7.71x
- Price / cash flow
- -50.06x
Enterprise value
- Enterprise value
- $9.4B
- EV / sales
- 7.33x
- EV / EBITDA
- -32.21x
- EV / EBIT
- -29.16x
- Market cap
- $9.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026